ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	13/119	120/7206	6.94921226183e-08
ko04064	NF-kappa B signaling pathway	11/119	96/7206	4.22882204135e-07
ko04380	Osteoclast differentiation	11/119	134/7206	1.16309487098e-05
ko04060	Cytokine-cytokine receptor interaction	13/119	191/7206	1.41111176362e-05
ko04658	Th1 and Th2 cell differentiation	9/119	96/7206	2.6195972667e-05
ko04621	NOD-like receptor signaling pathway	11/119	157/7206	5.14221119346e-05
ko04657	IL-17 signaling pathway	8/119	87/7206	8.59743611283e-05
ko05160	Hepatitis C	10/119	153/7206	0.00020334547152
ko04931	Insulin resistance	9/119	137/7206	0.000411093147529
ko05215	Prostate cancer	8/119	111/7206	0.000467464617388
ko04662	B cell receptor signaling pathway	7/119	88/7206	0.000590010673198
ko05167	Kaposi's sarcoma-associated herpesvirus infection	10/119	191/7206	0.00117435524439
ko05169	Epstein-Barr virus infection	10/119	206/7206	0.00206946799759
ko05161	Hepatitis B	9/119	173/7206	0.00216475321183
ko05212	Pancreatic cancer	6/119	83/7206	0.00239651797358
ko05206	MicroRNAs in cancer	9/119	177/7206	0.00252930694663
ko05200	Pathways in cancer	17/119	492/7206	0.00300710557263
ko04932	Non-alcoholic fatty liver disease (NAFLD)	9/119	182/7206	0.00305193673891
ko04330	Notch signaling pathway	5/119	62/7206	0.00344965877054
ko04622	RIG-I-like receptor signaling pathway	5/119	62/7206	0.00344965877054
ko02010	ABC transporters	4/119	39/7206	0.00372271067349
ko04660	T cell receptor signaling pathway	7/119	124/7206	0.0042986159236
ko04623	Cytosolic DNA-sensing pathway	4/119	41/7206	0.00446903270602
ko05145	Toxoplasmosis	7/119	126/7206	0.00469319462148
ko05142	Chagas disease (American trypanosomiasis)	7/119	130/7206	0.00556382946887
ko04620	Toll-like receptor signaling pathway	6/119	100/7206	0.00603617349399
ko04014	Ras signaling pathway	11/119	279/7206	0.00620076971515
ko04933	AGE-RAGE signaling pathway in diabetic complications	7/119	135/7206	0.00681642129746
ko05418	Fluid shear stress and atherosclerosis	8/119	173/7206	0.00767267007812
ko04659	Th17 cell differentiation	6/119	106/7206	0.00797709208606
ko05166	HTLV-I infection	11/119	292/7206	0.00862747591874
ko04210	Apoptosis	8/119	180/7206	0.00964477927367
ko05230	Central carbon metabolism in cancer	5/119	81/7206	0.0106672782452
ko05220	Chronic myeloid leukemia	5/119	85/7206	0.0129668772677
ko04320	Dorso-ventral axis formation	3/119	31/7206	0.014097203379
ko05162	Measles	6/119	120/7206	0.0141922384022
ko04066	HIF-1 signaling pathway	6/119	123/7206	0.0158693783469
ko00901	Indole alkaloid biosynthesis	1/119	1/7206	0.0165140160978
ko05120	Epithelial cell signaling in Helicobacter pylori infection	5/119	92/7206	0.0177583432761
ko04062	Chemokine signaling pathway	8/119	201/7206	0.0178391497603
ko05164	Influenza A	7/119	167/7206	0.0202847667929
ko05231	Choline metabolism in cancer	6/119	134/7206	0.0231899165334
ko05223	Non-small cell lung cancer	4/119	66/7206	0.0232348775306
ko04217	Necroptosis	7/119	178/7206	0.0275924812611
ko01521	EGFR tyrosine kinase inhibitor resistance	5/119	106/7206	0.0305596430596
ko00073	Cutin, suberine and wax biosynthesis	1/119	2/7206	0.0327575736396
ko05152	Tuberculosis	7/119	187/7206	0.0347714217189
ko05140	Leishmaniasis	4/119	75/7206	0.0350329229202
ko05202	Transcriptional misregulation in cancer	7/119	188/7206	0.0356390502687
ko04215	Apoptosis - multiple species	3/119	47/7206	0.0420867241175
ko04010	MAPK signaling pathway	10/119	321/7206	0.0432048106544
ko04072	Phospholipase D signaling pathway	7/119	197/7206	0.0441000309595
ko05219	Bladder cancer	3/119	48/7206	0.0443684490854
ko05131	Shigellosis	4/119	82/7206	0.0462266167199
ko04015	Rap1 signaling pathway	9/119	278/7206	0.0488716372929